Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization

Who is this study for? Adult patients with chronic pain
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Over 100 million Americans suffer from chronic pain resulting in annual cost of roughly $635 billion. Limited treatments are available for this widespread disease. The data supporting these treatments lack generalizability to patients with more serious medical and psychological comorbidities who are often excluded from explanatory efficacy trials. Our work aims to integrate randomized comparative effectiveness research with patient care. The investigators will randomize the patients and collect data using an open-source learning healthcare system already in use in our department to monitor patients' progress: Collaborative Health Outcomes Information Registry (CHOIR). Collaborative Health Outcomes Information Registry uses the National Institute of Health Patient Reported Outcomes Measurement Information System item banks for comparative metrics through computer adaptive testing. The investigators will leverage the advantage of this novel system to compare effectiveness of duloxetine and desipramine in decreasing pain in patients with chronic pain. The investigators will also compare adherence of patients to these two commonly used medications over a period of six months. This will evaluate feasibility of integrating randomized comparative effectiveness research with patient care in subspecialty clinics. Collaborative Health Outcomes Information Registry can then be applied for numerous future trials to advance our knowledge in perioperative and pain medicine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age of 18 years old or above

• Persistent pain for more than 3 months

• Candidate for treatment by anti-depressant based on treating pain provider

Locations
United States
California
Stanford Pain Management Center
RECRUITING
Redwood City
Contact Information
Primary
Vafi Salmasi, MD.
vsalmasi@stanford.edu
650-725-0246
Time Frame
Start Date: 2018-09-20
Estimated Completion Date: 2025-07-31
Participants
Target number of participants: 320
Treatments
Experimental: Duloxetine
Duloxetine starting at 20 mg per day and increasing to 60 mg per day as tolerated.
Experimental: Desipramine
Desipramine starting at 25 mg per day and increasing to 75 mg per day as tolerated.
Related Therapeutic Areas
Sponsors
Leads: Stanford University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials